震惊 !!!广西医科大学论文被质疑,涉及多组重复!尚待回复

学术   教育   2024-11-12 09:41   浙江  


Stroke





2021 Dec;52(12):4021-4032.

 doi: 10.1161/STROKEAHA.120.033285. Epub 2021 Nov 1.

CCR5 Activation Promotes NLRP1-Dependent Neuronal Pyroptosis via CCR5/PKA/CREB Pathway After Intracerebral Hemorrhage

Jun Yan # 1Weilin Xu # 2Cameron Lenahan 3Lei Huang 4 5Jing Wen 6Gaigai Li 7Xin Hu 8Wen Zheng 9John H Zhang 4 5 10Jiping Tang 5

Affiliations expand

  • PMID: 34719258

  •  

  • PMCID: PMC8607924

  •  

  • DOI: 10.1161/STROKEAHA.120.033285

Erratum in

  • Correction to: CCR5 Activation Promotes NLRP1-Dependent Neuronal Pyroptosis via CCR5/PKA/CREB Pathway After Intracerebral Hemorrhage.

    [No authors listed]Stroke. 2024 Jul;55(7):e232. doi: 10.1161/STR.0000000000000467. Epub 2024 Jun 24.PMID: 38913804 No abstract available.

Abstract

Background and purpose: Neuronal pyroptosis is a type of regulated cell death triggered by proinflammatory signals. CCR5 (C-C chemokine receptor 5)-mediated inflammation is involved in the pathology of various neurological diseases. This study investigated the impact of CCR5 activation on neuronal pyroptosis and the underlying mechanism involving cAMP-dependent PKA (protein kinase A)/CREB (cAMP response element binding)/NLRP1 (nucleotide-binding domain leucine-rich repeat pyrin domain containing 1) pathway after experimental intracerebral hemorrhage (ICH).

Methods: A total of 194 adult male CD1 mice were used. ICH was induced by autologous whole blood injection. Maraviroc (MVC)-a selective antagonist of CCR5-was administered intranasally 1 hour after ICH. To elucidate the underlying mechanism, a specific CREB inhibitor, 666-15, was administered intracerebroventricularly before MVC administration in ICH mice. In a set of naive mice, rCCL5 (recombinant chemokine ligand 5) and selective PKA activator, 8-Bromo-cAMP, were administered intracerebroventricularly. Short- and long-term neurobehavioral assessments, Western blot, Fluoro-Jade C, terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), and immunofluorescence staining were performed.

Results: The brain expression of CCL5 (chemokine ligand 5), CCR5, PKA-Cα (protein kinase A-Cα), p-CREB (phospho-cAMP response element binding), and NLRP1 was increased, peaking at 24 hours after ICH. CCR5 was expressed on neurons, microglia, and astrocytes. MVC improved the short- and long-term neurobehavioral deficits and decreased neuronal pyroptosis in ipsilateral brain tissues at 24 hours after ICH, which were accompanied by increased PKA-Cα and p-CREB expression, and decreased expression of NLRP1, ASC (apoptosis-associated speck-like protein containing a CARD), C-caspase-1, GSDMD (gasdermin D), and IL (interleukin)-1β/IL-18. Such effects of MVC were abolished by 666-15. At 24 hours after injection in naive mice, rCCL5 induced neurological deficits, decreased PKA-Cα and p-CREB expression in the brain, and upregulated NLRP1, ASC, C-caspase-1, N-GSDMD, and IL-1β/IL-18 expression. Those effects of rCCL5 were reversed by 8-Bromo-cAMP.

Conclusions: CCR5 activation promoted neuronal pyroptosis and neurological deficits after ICH in mice, partially through the CCR5/PKA/CREB/NLRP1 signaling pathway. CCR5 inhibition with MVC may provide a promising therapeutic approach in managing patients with ICH.

Keywords: cerebral hemorrhage; chemokine receptor; inflammasome; neuron; pyroptosis.

参考链接:https://pubpeer.com/publications/5AF4D4F47122EBA4C302FE61B42D61


本文为【丰倍SCI】公众号原创文章

未经授权禁止转载!

转载请勿更改原文内容及格式!

如有转载需求或合作事宜

可添加下方客服微信

或后台私信小编

三重保障:Al查重+机械物理查重+人工查重

官网:www.fengbei-ai.com


客服微信:sindy01010101

丰倍查重
专注科研图片查重二十年,专业、高效、品质。您的信任与支持是我们前进最大的动力!
 最新文章